Pulse Biosciences reports first use of pulsed-field ablation

Pulse Biosciences (Nasdaq:PLSE) today announced the completion of the first-in-human procedures for its CellFX nsPFA cardiac catheter.

Related Keywords

Prague , Praha , Hlavníesto , Czech Republic , California , United States , New York , Petr Neuzil , Kevin Danahy , Vivek Reddy , , Mount Sinai Hospital , Pulse Biosciences , Pulse Bioscience ,